Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Crump

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Time to Change Direction in the Treatment of Relapsed Hodgkin Lymphoma?Michael Crump
Hematology. American Society of Hematology. Education Program|December 17, 2008
Management of Hodgkin lymphoma in relapse after autologous stem cell transplantMichael Crump
The Lancet. Oncology|February 27, 2017
Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphomaMichael Crump
Blood|May 19, 2012
Hitting the target in MCLMichael Crump
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Toward risk-based breast cancer screening and prevention strategies for survivors of Hodgkin's lymphoma: one step closer?Michael Crump
Leukemia & Lymphoma|December 16, 2006
What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma?Michael Crump
The New England Journal of Medicine|April 20, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin’s LymphomaMichael Crump
Hematology/Oncology Clinics of North America|November 28, 2016
Management of Relapsed Diffuse Large B-cell LymphomaMichael Crump
Current Pharmaceutical Design|October 9, 2002
Inhibition of raf kinase in the treatment of acute myeloid leukemiaMichael Crump
Therapeutic Advances in Hematology|June 16, 2020
PET-adapted approaches to primary therapy for advanced Hodgkin lymphomaNoemie Lang, Michael Crump
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Time to Change Direction in the Treatment of Relapsed Hodgkin Lymphoma?Michael Crump
Hematology. American Society of Hematology. Education Program|December 17, 2008
Management of Hodgkin lymphoma in relapse after autologous stem cell transplantMichael Crump
The Lancet. Oncology|February 27, 2017
Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphomaMichael Crump
Blood|May 19, 2012
Hitting the target in MCLMichael Crump
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Toward risk-based breast cancer screening and prevention strategies for survivors of Hodgkin's lymphoma: one step closer?Michael Crump
Leukemia & Lymphoma|December 16, 2006
What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma?Michael Crump
The New England Journal of Medicine|April 20, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin’s LymphomaMichael Crump
Hematology/Oncology Clinics of North America|November 28, 2016
Management of Relapsed Diffuse Large B-cell LymphomaMichael Crump
Current Pharmaceutical Design|October 9, 2002
Inhibition of raf kinase in the treatment of acute myeloid leukemiaMichael Crump
Therapeutic Advances in Hematology|June 16, 2020
PET-adapted approaches to primary therapy for advanced Hodgkin lymphomaNoemie Lang, Michael Crump
Pageof 19